Baystreet Staff - Tuesday, October 3, 2006 AEterna Zentaris Inc. 12:45 PM EST - AEterna Zentaris Inc. : moved up 12 cents to $5.83 after it said a Phase 2 trial of its drug ozarelix to treat enlarged prostate glands produced positive data. AEterna Zentaris Inc. T.AEZ are trading up 14 cents at $5.85.